Strategic Implications: Analytical findings reported today underscore ABP-450’s potential to become the first full label therapeutic biosimilar to BOTOX® in the U.S., positioning AEON to address a >$3 ...
FDA Type 2a meeting scheduled for November 19, 2025, to review AEON’s analytical development plan and initial data –– Positive biosimilarity ...
craftwithfelicia on MSN
We Adopted a Baby! Meet the AEON Mira 5S — Our New “Baby Mira”
Say hello to our newest family member — the AEON Mira 5S! We’re beyond excited to welcome “Baby Mira” into our lives. Watch ...
AEON, the next generation crypto payment framework, today announced the release of its x402 SDK Version 2 on BNB Chain, enabling AI agents and API service providers to natively initiate and accept ...
STOCKHOLM, June 17, 2025 /CNW/ -- Hexagon, the global leader in measurement technology, launches a humanoid robot, AEON, at its flagship Hexagon LIVE Global event. AEON, launched by Hexagon's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback